Gilead gets US FDA nod for Trodelvy to treat metastatic triple-negative breast cancer
Trodelvy significantly reduced the risk of death by 49 per cent compared with single-agent chemotherapy in the Phase 3 ASCENT…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
metastatic triple-negative breast cancer
Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast…
Atezolizumbab is the first immunotherapy drug to be approved globally for treatment of unresectable locally advanced and…